Apoptotic cells actively inhibit the expression of CD69 on Con A activated T lymphocytes

Scandinavian Journal of Immunology

Volumn 51, Issue 3, 2000, Pages 231-236

  Sun, E ^a   Zhang, L ^a   Zeng, Y ^b   Ge, Q ^b   Zhao, M ^a   Gao, W ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CYCLOHEXIMIDE;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; CONCANAVALIN A; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HL-60 CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; K562 CELLS; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; PROPYLENE GLYCOLS; PROTEIN SYNTHESIS INHIBITORS; SPHINGOSINE; T-LYMPHOCYTE SUBSETS;

EID: 0034061719     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00666.x     Document Type: Article

References (28)

1. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediated recognition and phagocytosis of apoptotic cells. Nature 1998;392:505-9.
2. Tott KR. Therapeutic effects of low radiation doses. Strahlenther Onkol 1994;170:1-12.
3. Fadok VA, Brattib DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2 and PAF. J Clin Invest 1998;101:890-8.
4. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997;390: 350-1.
5. Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells Dayt 1994;12:456-65.
6. Craston R, Koh M, McDermott A, Ray N, Prentice HG, Lowdell MW. Temporal dynamics of CD69 expression on lymphoid cells. J Immunol Methods 1997;209:37-45.
7. Suzuki S, Li XK, Enosawa S, Shinomiya T. A new immunosuppressant, FTY720, induces bc1-2-associated apoptotic cell death in human lymphocytes. Immunology 1996;89:518-23.
8. Shinomiya T, Li XK, Amemiyu H, Suzuki S. An immunosuppressive agent, FTY720, increases intracellular concentration of calcium ion and induces apoptosis in HL-60. Immunology 1997;91:594-600.
9. Yuan J. Transducing signals of life and death. Curr Opin Cell Biol 1997;9:247-51.
10. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
11. Evan G, Littlewood T. A matter of life and cell death. Science 1998;281:1317-22.
12. Abbas AK. Die and let live: Eliminating dangerous lymphocytes. Cell 1996;84:655-7.
13. Griffith TS, Ferguson TA. The role of fasL-induced apoptosis in immune privilege. Immunol Today 1997;18:240-4.
14. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995;82:582-7.
15. Mincgeff MS, Getsov SI, Meryman HT. Mechanisms of alloimmunization and immunosuppression by blood transfusions in an inbred rodent model. Transplantation 1995;60:815-21.
16. Ponner BB, Stach C, Zoller O et al. Induction of apoptosis reduces immunogenicity of human T cell line in mice. Scan J Immunol 1998;47:343-7.
17. Gao Y, Herndon JM, ZHang H, Griffith TS, Ferguson TA. Antiinflammatory effects of CD95 lignad (FasL) induced apoptosis. J Exp Med 1998;188:887-96.
18. Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 1985; 56:351-38.
19. Savill J, Dransfield JI, Hogg N, Haslett C. Vitronectin receptor mediated phagocytosis of cells undergoing apoptosis. Nature 1990;343:170-3.
20. Walport MJ, Davies KA, Botto M. Clq and systemic lupus erythematosus. Immunobiology 1998;199:265-85.
21. Korb LC, Ahearn JM. Clq binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997;158:4525-8.
22. Ferguson TA, Griffith TS. A vision of cell death: Insights into immune privilege. Immunol Rev 1997;156:167-84.
23. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996;5:7-16.
24. Barr ML, Meiser BM, Eisen HJ et al. Photopheresis for the prevention of rejection in cardiac transplantation. N Eng J Med 1998; 339:1744-51.
25. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action. J Invest Dermatol 1996;107:235-42.
26. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
27. FU F, Li Y, Qian S et al. costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996;62:659-65.
28. Albert ML, Pearce FA, Francisco LM et al. Immature dendritic cells phagocytose apoptotic cells via αvβ and CD36, and cross present antigen to cytotoxic T cell lymphocytes. J Exp Med 1998;188:1359-68.